SEC Filings | NeuroBo Pharmaceuticals, Inc.

Filing date	Form	Description	Filing Group	View
Nov 4, 2022	EFFECT	EFFECT	Other	9999999995-22-003211.rtf 9999999995-22-003211.xls 9999999995-22-003211.pdf View HTML
Jan 31, 2023	EFFECT	EFFECT	Other	9999999995-23-000244.rtf 9999999995-23-000244.xls 9999999995-23-000244.pdf View HTML
Apr 23, 2024	EFFECT	EFFECT	Other	9999999995-24-001086.rtf 9999999995-24-001086.xls 9999999995-24-001086.pdf View HTML
Aug 5, 2016	FWP	FWP	Other	0001104659-16-137191.rtf 0001104659-16-137191.xls 0001104659-16-137191.pdf View HTML
Oct 24, 2022	FWP	FWP	Other	0001104659-22-110937.rtf 0001104659-22-110937.pdf View HTML
Mar 31, 2021	NT 10-K	Notification that form 10-K will be submitted late	Annual Filings	0001558370-21-003825.rtf 0001558370-21-003825.xls 0001558370-21-003825.pdf View HTML
May 18, 2020	NT 10-Q	Notification that form type 10-Q will be submitted late	Quarterly Filings	0001558370-20-006804.rtf 0001558370-20-006804.pdf View HTML
Sep 1, 2017	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	0001104659-17-055232.rtf 0001104659-17-055232.xls 0001104659-17-055232.pdf View HTML
Feb 2, 2021	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	0001104659-21-010556.rtf 0001104659-21-010556.xls 0001104659-21-010556.pdf View HTML
May 6, 2022	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	0001140361-22-018115.rtf 0001140361-22-018115.xls 0001140361-22-018115.pdf View HTML

Data provided by Kaleidoscope.